Anti Fingerprint Coatings

  The global next generation implants next generation implants (NGI) market is expected to reach a market size of USD 4.45 Billion in 2028 and register a steady CAGR during the forecast period, according to latest analysis by Emergen Research. Increasing global geriatric population with rising age-related bone diseases is a key factor driving demand for next generation implants. Major companies are focusing on development of next generation medical implants such as cardiac devices, retinal implants, neurostimulators, and blood pressure sensors, which can bring improvements in patients’ lives and help them to continue their daily activities with least amount of discomfort. The report sheds light on the mergers and acquisitions, collaborations, joint ventures, brand promotions and product launches, agreements and partnerships, and corporate and government deals. The comprehensive analysis of the competitive landscape offers the readers a deeper understanding about the competitors. A...

  The global oncolytic virus therapy oncolytic virus therapy market size is expected to reach USD 866.1 Million at a steady CAGR of 23.9% in 2028, according to latest analysis by Emergen Research. Steady growth of oncolytic virus therapy market can be attributed to rising cancer incidence globally. Cancer is a major cause of deaths in countries across the globe and it is estimated that in 2020, over 1.8 million new cancer cases were diagnosed in the US, with over 0.6 Million deaths occurring due to the disease. Also, around 70% of cancer mortality occurs in low and middle-income countries. Oncolytic virus therapy (a type of immunotherapy) uses engineered viruses to destroy cancer cells without affecting healthy cells in the human body. Once a cancer cell is destroyed, it releases cancer antigens that trigger immune responses to destroy other tumor cells in the body. The report sheds light on the mergers and acquisitions, collaborations, joint ventures, brand promotions and product...

  The global joint reconstruction joint reconstruction market is projected to reach a market size of USD 47.98 Billion in 2028 and register a steady CAGR over the forecast period, according to latest analysis by Emergen Research. Key factors driving market growth are increasing global geriatric population, increasing implementation of awareness initiatives and programs by government schemes, rising investments in the healthcare industry, and growing demand for more advanced and efficient technologies. The report sheds light on the mergers and acquisitions, collaborations, joint ventures, brand promotions and product launches, agreements and partnerships, and corporate and government deals. The comprehensive analysis of the competitive landscape offers the readers a deeper understanding about the competitors. Available Sample Report in PDF Version@  https://www.emergenresearch.com/request-sample/501 Competitive Terrain: The global Joint Reconstruction industry is highly consol...

  The global  interventional cardiology devices market size is expected to reach USD 26.84 Billion at a steady CAGR of 8.7% in 2028, according to latest analysis by Emergen Research. Steady growth of the interventional cardiology devices market can be attributed to rising incidence of cardiovascular diseases. Cardiovascular disease is the most common cause of death in the US, and is responsible for around 655,000 deaths every year. Coronary heart disease is the leading heart disease type that, in 2017, accounted for the deaths of 365,914 individuals in the US. Interventional cardiology devices deliver several benefits, including reduced chances of scar occurrence, reduced surgery complexity and time, and decreased pain. Additionally, rising incidence of cardiovascular diseases result in an increase in healthcare expenditure, which in turn, is driving revenue growth of the interventional cardiology devices market. According to the Centers for Disease Control and Prevention, hea...

  The global  bioanalytical testing services market size is expected to reach USD 4.33 Billion in 2028 at a steady CAGR, according to latest analysis by Emergen Research. Increasing emphasis on analytical testing of biosimilars and biologics, growing demand for outsourcing analytical testing services, and rising research and development expenditure in biopharmaceutical and pharmaceutical sectors are some key factors driving market revenue growth. Bioanalytical testing services involve quantitative analysis of compound and their metabolite in biological fluids, which includes blood, serum, urine, plasma, or tissue extracts. Bioanalytical program comprises several processes such as sample preparation, development of bioanalytical method, validation, ensuring quantitative outcome that demonstrate accuracy, selectivity, precision, and stability. Sample preparation is a process that includes cleaning up the test sample before starting analysis or concentrating the sample for impro...

  The global RNA transcriptomics market size is expected to reach USD 12.46 Billion in 2028 at a steady CAGR over the forecast period, according to latest analysis by Emergen Research. Steady market revenue growth can be attributed to increasing application of RNA sequencing in drug discovery, rising investment in pharmaceutical research by governments and various private investors, and increasing demand for customized medicines. RNA transcriptome analysis helps researchers to understand the distribution of genes and functional patterns of each gene present in an organism. This analysis assesses all elements of a transcript, such as non-coding RNAs, mRNAs, and microRNAs, to identify the transcriptional structure of genes and quantify each transcript's changing behavior at the development stage. Transcriptomics has a variety of applications in diagnostics and disease analysis. Transcriptome analysis has been widely used to study heterogeneity of tumors, classify tumors into molecula...

  The global  compound management market size is expected to reach USD 826.2 Million in 2028 at a steady CAGR, according to latest analysis by Emergen Research. Global compound management market revenue growth is driven by increasing focus on biological research, rapid rise and development of the biopharmaceutical and biobanking sectors, and growing number of clinical trials. Compound management is a process of managing chemical libraries. Systematic compound management is pivotal during the drug delivery process, where speed, throughput, traceability, and reliability are fundamental. Application of automated technology in compound management helps in faster processing, provides a much higher sample consistency in terms of accuracy of compound concentration, and maintains an even consistency of physical properties across multiple experimental runs. The report sheds light on the mergers and acquisitions, collaborations, joint ventures, brand promotions and product launches, ag...